Cipla has received a communication from the USFDA that the classification of Companys Goa manufacturing facility continues to be as Official Action Indicated OAI USFDA may continue to withhold product approvals from this facility till the outstanding observations are resolved The Company has an ongoing derisking plan in place for new product approvals The Company will work closely with the USFDA and is committed to address these within the stipulated time
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
